Selected Publications

Friedman Flack K, George M, Podolanczuk A, Kim J, Hoffman E, Johnson C, McGroder C, Smith B, Garcia C, Kreider M, Kawut S, Barr R.G, Anderson M, Bernstein E.: Antinuclear antibodies and progression of high attenuation areas on chest computed tomography: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. American Thoracic Society May 2023 Notes: Poster discussion session.

Friedman Flack K & Katzen J. : Revealing the rare: Pulmonary fibrosis from surfactant-related gene mutation. CHEST. 163(4): 744-745, Apr 2023.

Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson M, Hoffman E, Podolanczuk A, Yun J, McDermott G, Sparks J, Moll M, Rich S, Rotter J, Noth I, Ragu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake G, Cho M, Garcia C, Barr R.G, Bernstein E.: Association of rheumatoid arthritis-related antibodies, HLA-DRB1, and MUC5B (rs35705950) with high attenuation areas, forced vital capacity, and interstitial lung abnormalities. International Colloquium on Lung and Airway Fibrosis Oct 2022 Notes: Poster session.

Friedman Flack, K., Gao, G.M., Berstein, E., Johnson, C., Diamond, J., Benvenuto, L. Arcasoy, S., Greeland, J., Betancourt, L., Oyster, M., Brown, M., Kalman, L., Zaleski, D., Adler, J., Tevald, M., Balar, P., Patel, S., Medikonda, N., Kreider, M., Christie, J., Singer, J., Anderson, M.: Differences in body composition and frailty between lung transplant candidates with connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis. American Thoracic Society May 2022 Notes: Poster session.

Friedman Flack K, Grimm J, Haas A, Jarrar D, Szeto W, Palevsky H.: Massive hemoptysis secondary to an aortomediastinoparenchymal fistula. American Thoracic Society International Conference. Aug 2020 Notes: Virtual Poster session.

Friedman Flack K, Chu S, Ciunci C, Berman A, Kreider M, Porteous M.: The management and outcomes of patients with both interstitial lung disease and lung cancer. American Thoracic Society International Conference. Dallas, TX May 2019 Notes: Poster session.

Kolb JM*, Friedman Flack K*, Chatterjee-Murphy P, Desai J, Wallentin L, Ezekowitz M, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J. *co-first authors: Locations and mucosal lesions responsible for major gastrointestinal bleeding in patients on warfarin or dabigatran. Dig Dis Sci. 63(7): 1878-1889, Jul 2018.

Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz J, Ruff C, Nordio F, Mercuri M, Choi Y, Antman E, Braunwald E, Giugliano R.: Gastrointestinal bleeding with edoxaban versus warfarin: Results from the ENGAGE AF- TIMI 48 trial. Circ Cardiovasc Qual Outcomes 11(5): epub, May 2018.

Romanoff A, Schmidt H, McMurray M, Weltz C, Schwartzman M, Friedman K, Margolies L, Port E.: Who is ordering MRIs in newly diagnosed breast cancer patients? Am Surg. 84(3): 351-357, Mar 2018.

Friedman Flack K, Desai J, Kolb JM, Chatterjee P, Wallentin L, Ezekowitz M, Yusuf S, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J.: Major gastrointestinal bleeding is often caused by occult malignancy in patients receiving warfarin or dabigatran to prevent stroke and systemic embolism from atrial fibrillation. Clin. Gastroenterol. Hepatol. 15(5): 682-690, May 2017.